✦ LIBER ✦

A new anti-cancer drug in the market: Good news for investors or for patients?

✍ Scribed by Giovanni Apolone; Giovanni Tafuri; Francesco Trotta; Silvio Garattini

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Is complement good or bad for cancer pat

✍ Maciej M. Markiewski; John D. Lambris 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 365 KB

A philosophy of anti-infectives as a gui

✍ Carl Nathan; Ben Gold; Gang Lin; Melanie Stegman; Luiz Pedro Sorio de Carvalho; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 139 KB

Meta-analysis of the Alpha/Beta Ratio fo

✍ Ivan R. Vogelius; Søren M. Bentzen 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 543 KB

Meta-analysis of the α/β-ratio for Prost

✍ I. Vogelius; S.M. Bentzen 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Predictive markers for anti-EGFR antibod

✍ Eric Van Cutsem; Sabine Tejpar 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 72 KB

Helicobacter pyloriand nonsteroidal anti

✍ Rupert W. L. Leong; Francis K. L. Chan; Joseph J. Y. Sung 📂 Article 📅 2001 🏛 Springer Japan 🌐 English ⚖ 123 KB